195 results
Page 3 of 10
8-K
EX-99.1
d2da2t5s
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm
8-K
EX-99.2
jf3zjk7
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm
8-K
EX-99.2
pk6y87
5 Aug 21
Caladrius Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.2
ln0va
6 May 21
Caladrius Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
4:06pm
8-K
EX-99.2
swx1fe
25 Feb 21
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
4:07pm
424B5
k3abhyi047nihjr og3
16 Feb 21
Prospectus supplement for primary offering
4:49pm
424B5
krjm9vk
16 Feb 21
Prospectus supplement for primary offering
4:46pm
8-K
EX-99.1
obk2a5o7 x3uv
29 Jan 21
Regulation FD Disclosure
7:58am
8-K
EX-99.1
hxkm6hxj
11 Jan 21
Regulation FD Disclosure
4:07pm
8-K
EX-99.1
0uefo0qlww55 m7
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
EX-99.1
u8kybg8stle9fggj
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
424B5
4zh9t3 kle
26 May 20
Prospectus supplement for primary offering
4:02pm
424B5
tyfkc1bq3
27 Apr 20
Prospectus supplement for primary offering
7:30am
8-K
EX-99.2
r59ns5mkz78 acwq9k
5 Mar 20
Caladrius Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:07pm
8-K
EX-99.2
pb6pqv6rix
18 Nov 19
Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019
6:21am